First-generation versus second-generation drug-eluting stents in current clinical practice: updated evidence from a comprehensive meta-analysis of randomised clinical trials comprising 31 379 patients.

Open Heart · 2014 · PMC4189321 · PMID 25332803

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

borderline significantp=0.06so close (0.05 < p ≤ 0.1)

A borderline significant class effect favouring second-generation DES was sustained in the long-term analysis: OR 0.75 (95% CI 0.55 to 1.01) p=0.06, with odds of MI roughly halved in comparison with EES versus PES: OR 0.56 (95% CI 0.42 to 0.74) p<0.0001.

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.